CMS506v7: Safe Use of Opioids – Concurrent Prescribing

XMLWordPrintable

    • Type: Hosp Inpt eCQMs - Hospital Inpatient eCQMs
    • Resolution: Answered
    • Priority: High
    • Component/s: ValueSet
    • Lyn S. Gurney, RN, BSBL, CPHQ
    • (601) 249-1825
    • Southwest Mississippi Regional Medical Center
    • Hide
      Thank you for your question regarding CMS506v7, Safe Use of Opioids - Concurrent Prescribing. The intent of the "Schedule II, III and IV Opioid Medications" value set (OID2.16.840.1.113762.1.4.1046.241) is intended to capture Schedule II, III and IV Opioids not schedule I or V opioids. The measure developer will consider updates to the Schedule II, III and IV Opioid Medications value set in a future annual update.
       
      Regarding correcting your data for reporting, we recommend you submit your question about EH eCQM reporting to the QualityNet Question and Answer Tool. To submit a question go to the question entry page at https://cmsqualitysupport.servicenowservices.com/qnet_qa?id=ask_a_question
      • Enter the required information designated by a red asterisk “*”
      • Under the Question Details section
      o Program: select “IQR – Inpatient Quality Reporting”
      o Topic: select “eCQM”
      o Subject: enter a short description of your question
      o Please describe your question: enter your complete question
      Show
      Thank you for your question regarding CMS506v7, Safe Use of Opioids - Concurrent Prescribing. The intent of the "Schedule II, III and IV Opioid Medications" value set (OID2.16.840.1.113762.1.4.1046.241) is intended to capture Schedule II, III and IV Opioids not schedule I or V opioids. The measure developer will consider updates to the Schedule II, III and IV Opioid Medications value set in a future annual update.   Regarding correcting your data for reporting, we recommend you submit your question about EH eCQM reporting to the QualityNet Question and Answer Tool. To submit a question go to the question entry page at https://cmsqualitysupport.servicenowservices.com/qnet_qa?id=ask_a_question • Enter the required information designated by a red asterisk “*” • Under the Question Details section o Program: select “IQR – Inpatient Quality Reporting” o Topic: select “eCQM” o Subject: enter a short description of your question o Please describe your question: enter your complete question
    • CMS0506v7
    • Hide
      RXNORM code included in the Value Set provided by CMS to EPIC team including Schedule V controlled substance(s) when measure calls for:
      Medications at discharge Schedule II, III, & IV opioids and/or Schedule IV benzodiazepines.
      Show
      RXNORM code included in the Value Set provided by CMS to EPIC team including Schedule V controlled substance(s) when measure calls for: Medications at discharge Schedule II, III, & IV opioids and/or Schedule IV benzodiazepines.

      [Suggested solution text preserved from the Solution field after the response was posted:

      I've included a screenshot of ValueSet CMS provided for this measure to EPIC (See attached ValueSetCMSprovided.jpg) 
      Looking at this, you will see the Schedule V opioid controlled substance included. 

      Furthermore, we would like an answer provided to us with how far, since mandatory reporting began in 2023, we can go back and correct our data for resubmission to CMS pertaining to this metric.

      Epic requires an official statement from CMS acknowledging the error and to issue a new, corrected "value set" sans the identified error. Also, to audit the set for any other Schedule V opioid controlled substances and remove those as well.]

       

      To Whom It May Concern:
       
      Apparently, the value set provided by CMS to Epic for the metric CMS506v7 and/or prior versions had "codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution" grouped with the category of Schedule II - IV opioid controlled substances.
       
      Epic requires an official statement from CMS acknowledging the error and to issue a new, corrected "value set" sans the identified error.
       
      If you are unable to directly address this matter, please feel free to forward this message to those who are able to address this concern. 
       
      Furthermore, we would like an answer provided to us with how far, since mandatory reporting began in 2023, we can go back and correct our data for resubmission to CMS pertaining to this metric.
       
      From the following link, a listing for "Codeine preparations - 200 mg/(100 ml or 100 mg)" can be found:
      https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf
       
      The following is a snippet found after navigating to the aforementioned link and searching for, "Codeine preparations - 200 mg/(100 ml or 100 mg." 
      An oral solution containing 2 mg/mL of codeine phosphate and 20 mg/mL of guaifenesin is a federal Schedule V controlled substance.

        1. SVCSopioid.jpg
          SVCSopioid.jpg
          110 kB
        2. ValueSetCMSprovided.jpg
          ValueSetCMSprovided.jpg
          253 kB

            Assignee:
            Mathematica EH eCQM Team
            Reporter:
            Jathaniel B. Easterling
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: